Literature DB >> 5040111

New evidences of disturbances of mineralocorticoid activity in benign, uncomplicated essential hypertension.

J Genest, W J Nowaczynski, O Küchel, C Sasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5040111      PMCID： PMC2441256     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  13 in total

1.  Hypotensive action of progesterone in experimental and human hypertension.

Authors:  J G ARMSTRONG
Journal:  Proc Soc Exp Biol Med       Date:  1959-11

2.  Inhibition of the sodium-retaining influence of aldosterone by progesterone.

Authors:  R L LANDAU; K LUGIBIHL
Journal:  J Clin Endocrinol Metab       Date:  1958-11       Impact factor: 5.958

3.  The metabolic effects of progesterone in man.

Authors:  R L LANDAU; D M BERGENSTAL; K LUGIBIHL; M E KASCHT
Journal:  J Clin Endocrinol Metab       Date:  1955-10       Impact factor: 5.958

4.  Human arterial hypertension: a state of mild chronic hyperaldosteronism?

Authors:  J GENEST; G LEMIEUX; A DAVIGNON; E KOIW; W NOWACZYNSKI; P STEYERMARK
Journal:  Science       Date:  1956-03-23       Impact factor: 47.728

5.  The influence of estrogen and progesterone on aldosterone excretion.

Authors:  J C LAIDLAW; J L RUSE; A G GORNALL
Journal:  J Clin Endocrinol Metab       Date:  1962-02       Impact factor: 5.958

6.  Heparinoid-induced inhibition of aldosterone secretion in pregnant women. The role of augmented aldosterone secretion in sodium conservation during normal pregnancy.

Authors:  E N Ehrlich
Journal:  Am J Obstet Gynecol       Date:  1971-04-01       Impact factor: 8.661

7.  Studies of the renin-angiotensin-aldosterone system in patients with hypertension and in normal subjects.

Authors:  D H Streeten; F E Schletter; G V Clift; C T Stevenson; T G Dalakos
Journal:  Am J Med       Date:  1969-06       Impact factor: 4.965

8.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

9.  A decreased metabolic clearance rate of aldosterone in benign essential hypertension.

Authors:  W Nowaczynski; O Kuchel; J Genest
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

10.  Effects of sodium loading, sodium depletion and posture on plasma aldosterone concentration and renin activity in hypertensive patients.

Authors:  J A Luetscher; M H Weinberger; A J Dowdy; G W Nokes; H Balikian; A Brodie; S Willoughby
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958
View more
  3 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Aldosterone and renin in essential hypertension.

Authors:  J Genest; W Nowaczynski; R Boucher; O Kuchel; J M Rojo-Ortega
Journal:  Can Med Assoc J       Date:  1975-09-06       Impact factor: 8.262

Review 3.  Role of the adrenal cortex and sodium in the pathogenesis of human hypertension.

Authors:  J Genest; W Nowaczynski; R Boucher; O Kuchel
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.